Effectiveness of Betahistine in the Management of Vertigo
DOI:
https://doi.org/10.29303/jku.v11i4.812Kata Kunci:
Vertigo, Treatment, BetahistineAbstrak
Vertigo merupakan ilusi gerakan diri atau gerakan lingkungan. Keluhan ini menimbulkan beberapa sensasi disorientasi dalam ruang disertai dengan gangguan vegetatif (mual, muntah, berkeringat) atau gejala pendengaran (gangguan pendengaran, tinitus, perasaan penuh pada telinga). Vertigo posisional paroksismal jinak (BPPV), penyakit Ménière, dan neuritis vestibular merupakan kasus yang sering ditemukan dalam praktek klinis. Pengobatan vertigo biasanya mencakup penggunaan obat-obatan, terapi fisik, dan adaptasi gaya hidup. Modalitas farmakologis yang sering digunakan adalah betahistin untuk pengobatan penyakit Ménière dan BPPV. Betahistin mempunyai aktivitas memodulasi sistem histaminergik, menyebabkan vasodilatasi dan memperbaiki aliran darah ke koklea sehingga memperbaiki gejala vertigo.
Referensi
2. Labuguen RH. Initial evaluation of vertigo. Am Fam Physician. 2006;73(11–12):585–90.
3. Nur anggraini D, Wurllete WE, Permana WE. Menganalisis Dampak Penggunaan Betahistine Mesilate Terhadap Pasien Gejala Vertigo Perifer Di Klinik Al Ma’soem Cibulareng. J Sos Sains. 2021;1(10):1315–25.
4. Thursina C, Dewati E. Pedoman Tatalaksana Vertigo. Edisi kedu. Jakarta; 2017.
5. Ramos Alcocer R, Ledezma Rodríguez JG, Navas Romero A, Cardenas Nuñez JL, Rodríguez Montoya V, Deschamps J, et al. Use of betahistine in the treatment of peripheral vertigo. Acta Otolaryngol. 2015;135(12):1205–11.
6. Murdin L, Hussain K, Schilder AGM. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev. 2016;2013(8).
7. Pinzon RT, Sanyasi RDLR. Betahistine as a treatment for vertigo: A systematic review of randomized controlled trial. Asian J Pharm Pharmacol. 2018;4(1):6–12.
8. Indriawati KR, Pinzon RT. Dampak Penggunaan Betahistin Mesilate Terhadap Perbaikan Gejala Vertigo Perifer Di Rumah Sakit Bethesda Yogyakarta. Berk Ilm Kedokt Duta Wacana. 2017;2(3):427.
9. Sokolova L, Hoerr R, Mishchenko T. Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine . Int J Otolaryngol. 2014;2014:1–6.
10. Motamed H, Moezzi M, Rooyfard AD, Angali KA, Izadi Z. A Comparison of the Effects and Side Effects of Oral Betahistine with Injectable Promethazine in the Treatment of Acute Peripheral Vertigo in Emergency. J Clin Med Res. 2017;9(12):994–7.
11. Al?tamimi DJ, Ammoo AM, Alani ME, Ibraheem JJ. Pharmacokinetics and dose proportionality of betahistine in healthy individuals. Sci Pharm. 2020;88(1).
12. Lacour M. Betahistine treatment in managing vertigo and improving vestibular compensation: Clarification. J Vestib Res Equilib Orientat. 2013;23(3):139–51.
13. Biswas A, Dutta N. Role of Betahistine in the Management of Vertigo. Ann Otol Neurotol. 2018;01(02):051–7.
14. Parfenov VA, Golyk VA, Matsnev EI, Morozova S V., Melnikov OA, Antonenko LM, et al. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study. PLoS One. 2017;12(3):1–11.
15. Benecke H, Pérez-Garrigues H, Bin Sidek D, Uloziene I, Kuessner D, Sondag E, et al. Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: Experience in the OSVaLD study. Int Tinnitus J. 2010;16(1):14–24.
